Chemours (CC) Q2 EPS Jumps 53%

Chemours (NYSE:CC), a global chemicals manufacturer known for its fluoroproducts and titanium dioxide pigments, announced its results for Q2 2025 on August 5, 2025. The most notable news was a solid beat on both non-GAAP earnings and GAAP revenue expectations, with Adjusted earnings per share (non-GAAP) of $0.58, compared to the analyst consensus of $0.46. Revenue (GAAP) reached $1.6 billion, ahead of the $1.57 billion estimate. Operationally, the quarter saw outperformance in Thermal & Specialized Solutions thanks to Opteon™ refrigerants, and margin gains in Advanced Performance Materials, as measured by Adjusted EBITDA margin. However, a large $381 million net loss (GAAP) overshadowed those gains, primarily due to litigation and environmental settlement costs (GAAP). Overall, it was a mixed quarter: strong underlying business execution was offset by significant one-time legal costs and ongoing pressure in the Titanium Technologies segment. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Chemours manufactures specialty chemicals for a range of industries, including refrigeration, air conditioning, coatings, plastics, and electronics. Its main product lines include refrigerants like Opteon™ and Freon™, titanium dioxide pigments used in paints and plastics, and advanced materials for electronics and hydrogen applications.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool